FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)

View source ↗

Summary

FDA approved a supplemental application for Extraneal (icodextrin) submitted by Vantive US Healthcare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Extraneal (icodextrin)

Snippet

SUPPL AP for EXTRANEAL (ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)